PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Tilray Brands, Inc. (TLRY.TO)
2.000.05 (2.56%)
1.90 - 2.15
0.48 - 2.54
9.88M / 3.06M (Avg.)
-0.59 | -3.40
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
20.86%
Revenue growth at 75-90% of OGI.TO's 25.14%. Bill Ackman would push for innovation or market expansion to catch up.
-21.47%
Negative gross profit growth while OGI.TO is at 91.51%. Joel Greenblatt would examine cost competitiveness or demand decline.
-27.53%
Negative EBIT growth while OGI.TO is at 31.16%. Joel Greenblatt would demand a turnaround plan focusing on core profitability.
-27.53%
Negative operating income growth while OGI.TO is at 31.16%. Joel Greenblatt would press for urgent turnaround measures.
686.38%
Net income growth above 1.5x OGI.TO's 31.06%. David Dodd would check if a unique moat or cost structure secures superior bottom-line gains.
671.43%
Positive EPS growth while OGI.TO is negative. John Neff might see a significant comparative advantage in per-share earnings dynamics.
669.28%
Positive diluted EPS growth while OGI.TO is negative. John Neff might view this as a strong relative advantage in controlling dilution.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-12852.71%
Negative OCF growth while OGI.TO is at 93.36%. Joel Greenblatt would demand a turnaround plan focusing on real cash generation.
5.64%
FCF growth under 50% of OGI.TO's 31.48%. Michael Burry would suspect weaker operating efficiencies or heavier capex burdens.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-1150.19%
Negative 10Y OCF/share CAGR while OGI.TO stands at 0.00%. Joel Greenblatt would scrutinize managerial effectiveness and product competitiveness.
-1150.19%
Negative 5Y OCF/share CAGR while OGI.TO is at 83.78%. Joel Greenblatt would question the firm’s operational model or cost structure.
-11.55%
Negative 3Y OCF/share CAGR while OGI.TO stands at 96.64%. Joel Greenblatt would demand an urgent turnaround in the firm’s cost or revenue drivers.
2791.98%
10Y net income/share CAGR of 2791.98% while OGI.TO is zero. Bruce Berkowitz would see if minor gains can compound into a bigger lead over time.
2791.98%
5Y net income/share CAGR above 1.5x OGI.TO's 55.12%. David Dodd would confirm if the firm’s strategy is more effective in generating mid-term profits.
4465.63%
3Y net income/share CAGR above 1.5x OGI.TO's 14.69%. David Dodd would confirm the company’s short-term strategies outmatch the competitor significantly.
1891.94%
Equity/share CAGR of 1891.94% while OGI.TO is zero. Bruce Berkowitz might see a slight advantage that can compound significantly over 10 years.
1891.94%
5Y equity/share CAGR is in line with OGI.TO's 2055.57%. Walter Schloss would see parallel mid-term profitability and retention policies.
4563.18%
3Y equity/share CAGR above 1.5x OGI.TO's 532.66%. David Dodd verifies the company’s short-term capital management far exceeds the competitor’s pace.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
98.77%
AR growth is negative/stable vs. OGI.TO's 340.90%, indicating tighter credit discipline. David Dodd confirms it doesn't hamper actual sales.
63.89%
Inventory growth well above OGI.TO's 32.18%. Michael Burry suspects overshooting production or weaker sell-through vs. the competitor.
11.84%
Asset growth above 1.5x OGI.TO's 4.10%. David Dodd checks if M&A or new capacity expansions are value-accretive vs. competitor's approach.
13.20%
Under 50% of OGI.TO's 326.43%. Michael Burry raises concerns about the firm’s ability to build intrinsic value relative to its rival.
5.20%
We have some new debt while OGI.TO reduces theirs. John Neff sees the competitor as more cautious unless our expansions pay off strongly.
96.49%
R&D growth of 96.49% while OGI.TO is zero. Bruce Berkowitz checks if the moderate investment leads to meaningful product differentiation.
97.59%
SG&A growth well above OGI.TO's 3.66%. Michael Burry sees potential margin erosion unless it translates into higher sales or brand equity.